Cite
HARVARD Citation
Friedlander, M. et al. (2018). Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy. British journal of cancer. 119 (9), pp. 1075-1085. [Online].